Expansion of Circulating Tumor Cells from Patients with Locally Advanced Pancreatic Cancer Enable Patient Derived Xenografts and Functional Studies for Personalized Medicine

Expansion of Circulating Tumor Cells from Patients with Locally Advanced Pancreatic Cancer Enable Patient Derived Xenografts and Functional Studies for Personalized Medicine

Improvement in pancreatic cancer treatment represents an urgent medical goal that has been hampered by the lack of predictive biomarkers. Circulating Tumor Cells (CTCs) may be able to overcome this issue by allowing the monitoring of therapeutic response and tumor aggressiveness through ex vivo expa...

Full description

Bibliographic Details
Main Authors: Lianette Rivera-Báez, Ines Lohse, Eric Lin, Shreya Raghavan, Sarah Owen, Ramdane Harouaka, Kirk Herman, Geeta Mehta, Theodore S. Lawrence, Meredith A. Morgan, Kyle C. Cuneo, Sunitha Nagrath
Format: Article
Language:English
Published: MDPI AG 2020-04-01
Series:Cancers
Subjects:
circulating tumor cells
biomarkers
pancreatic cancer
personalized medicine
Online Access:https://www.mdpi.com/2072-6694/12/4/1011

Internet

https://www.mdpi.com/2072-6694/12/4/1011

Similar Items